738 related articles for article (PubMed ID: 36330513)
21. Development of the expression and prognostic significance of m
Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
[TBL] [Abstract][Full Text] [Related]
22. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
Zhu Y; He J; Li Z; Yang W
BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
[TBL] [Abstract][Full Text] [Related]
23. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer.
Chen ZH; Lin YL; Chen SQ; Yang XY
World J Gastrointest Oncol; 2023 Nov; 15(11):1951-1973. PubMed ID: 38077636
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.
Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J
J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
Wang B; Hou C; Yu X; Liu J; Wang J
Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
[TBL] [Abstract][Full Text] [Related]
26. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
[No Abstract] [Full Text] [Related]
27. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
28. Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma.
Kong R; Wang N; Zhou CL; Lu J
J Microbiol Biotechnol; 2024 Apr; 34(4):958-968. PubMed ID: 38494878
[TBL] [Abstract][Full Text] [Related]
29. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
Li C; Zheng L; Xu G; Yuan Q; Di Z; Yang Y; Dong X; Hou J; Wu G
Front Endocrinol (Lausanne); 2023; 14():1154741. PubMed ID: 37538794
[TBL] [Abstract][Full Text] [Related]
30. Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer.
Wang J; Zhang X; Zheng F; Yang Q; Bi F
J Ovarian Res; 2023 Aug; 16(1):177. PubMed ID: 37633972
[TBL] [Abstract][Full Text] [Related]
31. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
[TBL] [Abstract][Full Text] [Related]
33. Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiforme.
Luan J; Zhang D; Liu B; Yang A; Lv K; Hu P; Yu H; Shmuel A; Zhang C; Ma G
J Transl Med; 2024 Jan; 22(1):107. PubMed ID: 38279111
[TBL] [Abstract][Full Text] [Related]
34. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
Yu Z; Zhu Y; Ji J
Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
[TBL] [Abstract][Full Text] [Related]
35. Predictive significance of glycolysis-associated lncRNA profiles in colorectal cancer progression.
Mao R; Xu C; Zhang Q; Wang Z; Liu Y; Peng Y; Li M
BMC Med Genomics; 2024 Apr; 17(1):112. PubMed ID: 38685060
[TBL] [Abstract][Full Text] [Related]
36. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
[TBL] [Abstract][Full Text] [Related]
37. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer.
Li F; Ma J; Yan C; Qi Y
Am J Transl Res; 2022; 14(11):8064-8084. PubMed ID: 36505280
[TBL] [Abstract][Full Text] [Related]
38. The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients.
Chen W; Deng J; Zhou Y
Medicine (Baltimore); 2023 Mar; 102(10):e33114. PubMed ID: 36897681
[TBL] [Abstract][Full Text] [Related]
39. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
[TBL] [Abstract][Full Text] [Related]
40. Identification of m
Ma Y; Sun Y; Zhao X; Li J; Fu X; Gong T; Zhang X
Sci Rep; 2023 Sep; 13(1):14499. PubMed ID: 37666951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]